Edwards Lifesciences Corporation , the world leader in heart valve technologies, is scheduled to participate in the Piper Jaffray 17th Annual Health Care Conference at the Pierre New York Hotel in New York on Tuesday, January 25, 2005.
Stuart L. Foster, Edwards Lifesciences' Corporate Vice President, Technology and Discovery, will speak to the attendees of the conference at 1:30 p.m. EST. A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences' investor relations website at http://www.edwards.com/AboutUs/InvestorInformation or directly accessed via the following link: http://www.piperjaffray.com/hcwebcast. An archived version of the webcast will be available later that day on the Edwards' investor relations website in the News and Events section.
About Edwards Lifesciences
Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies. The company's global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, Fogarty, LifeStent, PERIMOUNT and Swan-Ganz. Additional company information can be found at http://www.edwards.com/.
Edwards Lifesciences and Edwards are trademarks of Edwards Lifesciences Corporation. Carpentier-Edwards, Cosgrove-Edwards, Fogarty, PERIMOUNT and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the U.S. Patent and Trademark Office. LifeStent is a trademark of Edwards Lifesciences AG and is registered in the U.S. Patent and Trademark Office.
SOURCE: Edwards Lifesciences Corporation
CONTACT: Investors, David K. Erickson, +1-949-250-6826, or Media, Barry
R. Liden, +1-949-250-5070, both of Edwards Lifesciences Corporation
# # #